Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines

International Journal of Cancer

Volumn 11, Issue 3, 1973, Pages 499-520

  Reedman, Beverley M ^a   Klein, George ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FIXING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIGEN LOCALIZATION; BURKITT LYMPHOMA; CANCER; CELL CULTURE; CELL NUCLEUS; CELL TRANSFORMATION; COMPLEMENT FIXATION TEST; COMPLEMENT FIXING ANTIGEN; EXPERIMENTAL ANIMAL; HERPES VIRUS SAIMIRI; IN VITRO STUDY; LYMPHOBLAST; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; LYMPHOID CELL LINE; MAJOR CLINICAL STUDY; METHODOLOGY; THEORETICAL STUDY; VIRUS; VIRUS GENOME; VIRUS TRANSFORMATION;

ANIMAL; ANTIGENS, NEOPLASM; BIOPSY; BREAST NEOPLASMS; BURKITT LYMPHOMA; CELL LINE; CENTRIFUGATION; COMPLEMENT FIXATION TESTS; CYTOMEGALOVIRUS INFECTIONS; CYTOPLASM; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GUINEA PIGS; HAPLORHINI; HERPESVIRUS 4, HUMAN; HUMAN; IMMUNE SERA; L CELLS (CELL LINE); LYMPHOCYTE ACTIVATION; MICE; NASOPHARYNGEAL NEOPLASMS; NEUROGLIA; RABBITS; STAINING AND LABELING;

EID: 0015827836     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910110302     Document Type: Article

References (49)

1. Complement fixation tests with cell lines derived from Burkitt's lymphoma and acute leukaemias
2. Cell line initiation from cord blood leukocytes treated with viruses, chemicals and radiation
3. Continuous culture of seven new lines (SKL‐1 to 7) from patients with acute leukemia
4. Epstein‐Barr virus‐associated antibody patterns in carcinoma of the post‐nasal space
5. Studies on the infectivity and cytopathology of Epstein‐Barr virus in human lymphoblastoid cells
6. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji)
7. Seroepidemiologic studies of infectious mononucleosis with EB virus
8. Fluorescence complement fixation by lymphoblastoid cells
9. Host cell macromolecular synthesis in cells containing EBV‐induced early antigens, studied by combined immunofluorescence and radioautography
10. The action of DNA antagonists on Epstein‐Barr virus (EBV)‐associated early antigen (EA) in Burkitt lymphoma lines
11. Staining of complement and modifications of fluorescent antibody procedures
12. Serologic evidence that a herpes‐type virus is the etiologic agent of heterophilepositive infectious mononucleosis
13. Immunofluorescence in cells derived from Burkitt's lymphoma
14. Studies on cell lines derived from Burkitt's lymphoma
15. Antibodies to Epstein‐Barr virus in Burkitt's lymphoma and control groups
16. Relation of Burkitt's tumor‐associated herpes‐type virus to infectious mononucleosis
17. Antibodies to Epstein‐Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and control groups
18. Antibodies to early Epstein‐Barr virus‐induced antigens in Burkitt's lymphoma
19. Demonstration of two distinct components in the early antigen complex of Epstein‐Barr virus‐infected cells
20. Cloning of immunoglobulin‐producing human leukemic and lymphoma cells in long term cultures
21. Studies on the complement‐fixing antigens of poliomyelitis. III. Intracellular development of antigen
22. Evaluation of the complement method of fluorescent antibody technique with myxoviruses
23. Cultivation in vitro of myelobasts from human leukemia
24. Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines
25. Antinuclear antibodies in infectious mononucleosis
26. Surface IgM kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines
27. Two‐colour immunofluorescence studies on EBV‐determined antigens
28. Three degrees of guanilic acidinosinic acid pyrophosphorylase deficiency in mouse flbroblasts
29. Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein‐Barr virus and neutralization by human sera with Epstein‐Barr virus antibody
30. Infectious mononucleosis: clinical manifestations in relation to EB virus antibodies
31. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV
32. Detection of Epstein‐Barr viral genome in non‐productive cells
33. Establishment of cell lines from Australian leukaemic patients: presence of a herpes‐like virus
34. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes‐like virus
35. Significance of a complement‐fixing antigen associated with herpes‐like virus and detected in the Raji cell line
36. Growth and antigenic properties of a biopsy‐derived Burkitt's lymphoma in thymus‐less (nude) mice
37. A study of malignant tumours in Nigeria by short term tissue culture
38. Lymphoid cell‐culture line derived from lymph node of marmoset infected with
39. Identity of the soluble EBV‐associated antigens of human lymphoid cell lines
40. Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines
41. Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines
42. Studies of the EB virus‐related antigens of human leukocyte cell lines
43. Some factors affecting membrane immunofluorescence reactivity of Burkitt lymphoma tissue culture cell lines
44. High incidence of antinuclear antibodies in the sera of nasopharyngeal cancer patients
45. Occurrence of Epstein‐Barr virus genomes in human lymphoblastoid cell lines
46. Presence of EB virus nucleic acid homology in a “virus‐free” line of Burkitt tumor cells
47. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx